Needle-free diabetes care: 7 devices that painlessly monitor blood …
WEBOct 7, 2022 · D-Base is a shoebox-sized blood sugar monitor developed by the German firm DiaMonTech. The device measures blood sugar levels by beaming an infrared laser through the skin of a finger and causing glucose in the skin to convert the light to heat. The machine then calculates glucose levels based on the increase of heat in the skin.
What trends will shape the biotech industry in 2024?
WEBJan 25, 2024 · Experts in the field believe that the biotech industry is poised for recovery in 2024, and one reason for that would be a favorable climate for M&A activity. A PwC report predicts the M&A deal totals could range from $225 billion to $275 billion. M&A will be among the trends that will influence the biotech market in 2024.
The twelve hottest biotech companies in the Boston area
WEBMar 12, 2024 · The Boston region has sprouted many influential public biotech companies. One of the most successful in recent years was Moderna, a giant messenger RNA (mRNA) specialist incubated by the VC firm Flagship Pioneering. Moderna would go on to produce one of the first COVID-19 vaccines in 2020. Another prestigious name, Vertex Pharmaceuticals, one ...
Labiotech.eu - Europe's leading Biotech News Website
WEB2 days ago · ADCs that deliver: The secret lies in rigorous characterization. Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective development. Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
10 neuroscience biotech companies you should know about
WEBAug 15, 2024 · Developing treatments for neurological diseases presents a huge challenge for neuroscience companies within the biotech industry. The central nervous system (CNS) is extremely complex and many neurological diseases can be difficult to treat due to the limited regenerative capacity of the CNS, and the fact that the blood-brain barrier – a specialized system of cells that blocks harmful ...
18 biotech companies in Switzerland to keep an eye on in 2024
WEBJul 2, 2024 · ALE.C04 is the Swiss biotech’s lead candidate in oncology. This monoclonal antibody targets CLDN1+ tumors and is currently in a phase 1/2 clinical trial for head and neck squamous cell carcinoma (HNSCC). It is being tested both as a monotherapy and in combination with pembrolizumab, an anti-PD-1 antibody.
Nineteen biotech companies in France making a difference
WEBJan 23, 2024 · France’s biotech industry stands at the forefront of global healthcare advancements. Home to a vibrant ecosystem of pioneering biotech companies, France blends a rich history of medical research with cutting-edge technology, fostering developments that are pivotal in tackling some of the most pressing health challenges of …
ALS: how close are we to a cure? - Labiotech.eu
WEBMar 4, 2024 · Most ALS cases are sporadic, while about 8–10% are inherited. While the average survival time after an ALS diagnosis is three years, still, about 20% of people with ALS live for five years or more, and 5% of people diagnosed with ALS have a life expectancy beyond 20 years. A well-known example for the slow progression of …
2024 biotech conferences and events - Labiotech.eu
WEBVirtual biotech conferences and events in 2024. B. Riley Securities’ 4th Annual Oncology Conference. 20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies. The 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies. 14th Annual International Symposium on Ovarian Cancer and Other ...
15 biotech companies shaking up the scene in Cambridge
WEBOct 6, 2022 · Founded: 2012. Cambridge Epigenetix was founded by Cambridge professor Sir Shankar Balasubramanian, who co-invented the technology behind next-generation sequencing now used by DNA sequencing giant Illumina. Cambridge Epigenetix pioneered epigenetic tests for the early detection of cancer and other diseases.